Tiga Teknologi Kesehatan Deteksi Toilet Ini Akan Diuji Secara Klinis Di AS, Israel dan Jepang

Tiga Teknologi Kesehatan Deteksi Toilet Ini Akan Diuji Secara Klinis Di AS, Israel dan Jepang

Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 Juni. The technology gains life-saving medical insights by analysing human excrement. Perusahaan telah mengajukan serangkaian tiga paten yang mencakup elemen sensor toilet medisnya.

Three Toilets Detection Health Technologies

The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, Eropa, Jepang dan Cina.

A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, Teknologi OutSense dapat mengidentifikasi sumber darah di sepanjang saluran pencernaan.

A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.

Menurut CEO OutSense Yfat Scialom, who predicts that “dengan ledakan pengobatan digital, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, penyakit radang usus dan infeksi saluran kemih.

Its solution consists of a multispectral optical sensor, sumber cahaya dan perangkat penyaringan otonom yang mencakup koneksi WiFi. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.

OutSense has developed tools to diagnose abnormalities in human excreta. Informasi diperoleh dari sampel darah, dikombinasikan dengan analisis tambahan waktu mulai dari pendarahan hingga ekskresi, memberikan rincian patologi perdarahan. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.

At the beginning of June, OutSense mengumumkan bahwa CommuniCare, sebuah perusahaan kesehatan besar dengan lebih dari 90 healthcare facilities in the US, akan mulai menguji coba teknologinya tahun ini. Selain percontohan ini, OutSense also plans to conduct clinical trials in Israel and Japan.

Kunjungi Berita Lainnya di Berita Viga.cc